Article Details

GigaGen Doses First Patient in Phase 1 Trial of Recombinant Hyperimmune Polyclonal ...

Retrieved on: 2024-04-08 21:15:02

Tags for this article:

Click the tags to see associated articles and topics

GigaGen Doses First Patient in Phase 1 Trial of Recombinant Hyperimmune Polyclonal .... View article details on hiswai:

Excerpt

“Unlike monoclonal antibodies, GIGA-2050 binds to thousands of viral epitopes. As a result, GIGA-2050 has strong neutralizing activity against ...

Article found on: www.theglobeandmail.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo